Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 2 (2005), Issue 4 (April)

1. Early time course of neointima formation and vascular remodelling following percutaneous coronary intervention and vascular brachytherapy of in-stent restenotic lesions as assessed by intravascular ultrasound analysis.
   Z Kardiol, 94(4): 239-46. [Abstract] [Full-text]
2. Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.
   Blood, 105(8): 3035-41. [Abstract] [Full-text]
3. Secondary neoplasms after radiotherapy for a childhood solid tumor.
   Pediatr Hematol Oncol, 22(2): 89-101. [Abstract] [Full-text]
4. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
   Mol Pharm, 2(2): 151-6. [Abstract] [Full-text]
5. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study.
   Ophthalmology, 112(4): 567-73. [Abstract] [Full-text]
6. Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma.
   Biol Blood Marrow Transplant, 11(4): 314-8. [Abstract] [Full-text]
7. Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation.
   Biol Blood Marrow Transplant, 11(4): 288-96. [Abstract] [Full-text]
8. Waiting times for radiotherapy: variation over time and between cancer networks in southeast England.
   Br J Cancer, 92(7): 1201-8. [Abstract] [Full-text]
9. A 3D photon superposition/convolution algorithm and its foundation on results of Monte Carlo calculations.
   Phys Med Biol, 50(8): 1767-90. [Abstract] [Full-text]
10. A finite size pencil beam for IMRT dose optimization.
    Phys Med Biol, 50(8): 1747-66. [Abstract] [Full-text]
11. Development and operation of a pixel segmented liquid-filled linear array for radiotherapy quality assurance.
    Phys Med Biol, 50(8): 1703-16. [Abstract] [Full-text]
12. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
    Clin Cancer Res, 11(7): 2727-34. [Abstract] [Full-text]
13. Stereotactic radiosurgery: the patient's experience.
    Soc Sci Med, 60(11): 2561-73. [Abstract] [Full-text]
14. Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damage.
    Gene Ther, 12(8): 685-93. [Abstract] [Full-text]
15. In vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy.
    Int J Radiat Oncol Biol Phys, 61(5): 1603-6. [Abstract] [Full-text]
16. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Int J Radiat Oncol Biol Phys, 61(5): 1596-602. [Abstract] [Full-text]
17. Error in the delivery of radiation therapy: results of a quality assurance review.
    Int J Radiat Oncol Biol Phys, 61(5): 1590-5. [Abstract] [Full-text]
18. Quantifying IOHDR brachytherapy underdosage resulting from an incomplete scatter environment.
    Int J Radiat Oncol Biol Phys, 61(5): 1582-6. [Abstract] [Full-text]
19. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
    Int J Radiat Oncol Biol Phys, 61(5): 1572-81. [Abstract] [Full-text]
20. Treatment planning of stereotactic radiotherapy for solitary lung tumor.
    Int J Radiat Oncol Biol Phys, 61(5): 1565-71. [Abstract] [Full-text]
21. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.
    Int J Radiat Oncol Biol Phys, 61(5): 1467-72. [Abstract] [Full-text]
22. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
    Int J Radiat Oncol Biol Phys, 61(5): 1460-6. [Abstract] [Full-text]
23. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys, 61(5): 1432-8. [Abstract] [Full-text]
24. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Int J Radiat Oncol Biol Phys, 61(5): 1393-402. [Abstract] [Full-text]
25. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Int J Radiat Oncol Biol Phys, 61(5): 1385-92. [Abstract] [Full-text]
26. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
    Int J Radiat Oncol Biol Phys, 61(5): 1306-16. [Abstract] [Full-text]
27. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 61(5): 1299-305. [Abstract] [Full-text]
28. Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation.
    Int J Radiat Oncol Biol Phys, 61(5): 1291-8. [Abstract] [Full-text]
29. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study.
    J Thorac Cardiovasc Surg, 129(4): 813-8. [Abstract] [Full-text]
30. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
    Nucl Med Biol, 32(3): 269-78. [Abstract] [Full-text]
31. Evolution of vascular brachytherapy over time: data from the RENO-registry analysis.
    Int J Cardiol, 100(2): 225-8. [Abstract] [Full-text]
32. Monitoring of hepatocellular carcinoma, following proton radiotherapy, with contrast-enhanced color Doppler ultrasonography.
    J Gastroenterol, 40(3): 283-90. [Abstract] [Full-text]
33. Purine level regulation during energy depletion associated with graded excitatory stimulation in brain.
    Neurol Res, 27(2): 139-48. [Abstract] [Full-text]
34. Intracoronary brachytherapy for treatment of in-stent restenosis.
    Cardiol Rev, 13(3): 139-41. [Abstract] [Full-text]
35. Surgical and radiosurgical management of brain metastases.
    Surg Clin North Am, 85(2): 329-45. [Abstract] [Full-text]
36. Radiation-induced conduction block: resolution following anticoagulant therapy.
    Muscle Nerve, 31(5): 642-5. [Abstract] [Full-text]
37. Detection and correction of patient movement in prostate brachytherapy seed reconstruction.
    Phys Med Biol, 50(9): 2071-87. [Abstract] [Full-text]
38. IMRT planning on adaptive volume structures--a decisive reduction in computational complexity.
    Phys Med Biol, 50(9): 2033-53. [Abstract] [Full-text]
39. IMRT sequencing for a six-bank multi-leaf system.
    Phys Med Biol, 50(9): 2015-31. [Abstract] [Full-text]
40. Measurements of primary off-axis ratios in wedged asymmetric photon fields: a formalism for dose and monitor unit calculations.
    Phys Med Biol, 50(9): 2003-14. [Abstract] [Full-text]
41. Dosimetric accuracy of a staged radiosurgery treatment.
    Phys Med Biol, 50(9): 1991-2002. [Abstract] [Full-text]
42. Three-dimensional dose verification of the clinical application of gamma knife stereotactic radiosurgery using polymer gel and MRI.
    Phys Med Biol, 50(9): 1979-90. [Abstract] [Full-text]
43. Comparison of dosimetric standards of USA and France for HDR brachytherapy.
    Phys Med Biol, 50(9): 1961-78. [Abstract] [Full-text]
44. Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphoma.
    Ann Oncol, 16(5): 786-92. [Abstract] [Full-text]
45. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
46. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
    Br J Cancer, 92(8): 1372-81. [Abstract] [Full-text]
47. The pathology of ionizing radiation as defined by morphologic patterns.
    Acta Oncol, 44(1): 13-22. [Abstract] [Full-text]
48. Postprostatectomy adjuvant versus salvage radiotherapy: a complication-adjusted number-needed-to-treat analysis.
    Cancer, 103(9): 1833-42. [Abstract] [Full-text]
49. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
    Head Neck, 27(5): 353-61. [Abstract] [Full-text]
50. Chronomodulation of topotecan or X-radiation treatment increases treatment efficacy without enhancing acute toxicity.
    Int J Radiat Oncol Biol Phys, 62(1): 230-7. [Abstract] [Full-text]
51. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
    Int J Radiat Oncol Biol Phys, 62(1): 198-206. [Abstract] [Full-text]
52. High-dose regions versus likelihood of cure after prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 62(1): 170-4. [Abstract] [Full-text]
53. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
    Int J Radiat Oncol Biol Phys, 62(1): 164-9. [Abstract] [Full-text]
54. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer.
    Int J Radiat Oncol Biol Phys, 62(1): 154-63. [Abstract] [Full-text]
55. Definitive radiation therapy for squamous cell carcinoma of the vagina.
    Int J Radiat Oncol Biol Phys, 62(1): 138-47. [Abstract] [Full-text]
56. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Int J Radiat Oncol Biol Phys, 62(1): 131-7. [Abstract] [Full-text]
57. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Int J Radiat Oncol Biol Phys, 62(1): 125-30. [Abstract] [Full-text]
58. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?
    Int J Radiat Oncol Biol Phys, 62(1): 118-24. [Abstract] [Full-text]
59. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Int J Radiat Oncol Biol Phys, 62(1): 111-7. [Abstract] [Full-text]
60. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 62(1): 76-81. [Abstract] [Full-text]
61. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report.
    Int J Radiat Oncol Biol Phys, 62(1): 53-61. [Abstract] [Full-text]
62. Stereotactic proton beam therapy for intracranial arteriovenous malformations.
    Int J Radiat Oncol Biol Phys, 62(1): 44-52. [Abstract] [Full-text]
63. Where to locate the isocenter? The treatment strategy for repeat trigeminal neuralgia radiosurgery.
    Int J Radiat Oncol Biol Phys, 62(1): 38-43. [Abstract] [Full-text]
64. Gamma knife radiosurgery of radiation-induced intracranial tumors: local control, outcomes, and complications.
    Int J Radiat Oncol Biol Phys, 62(1): 32-7. [Abstract] [Full-text]
65. Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative.
    Int J Radiat Oncol Biol Phys, 62(1): 3-19. [Abstract] [Full-text]
66. Pituitary radiotherapy.
    Endocrinol Metab Clin North Am, 34(2): 479-87, xi. [Abstract] [Full-text]
67. Optimized 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine.
    Magn Reson Med, 53(5): 1166-71. [Abstract] [Full-text]
68. The significance of rectal bleeding after pelvic radiotherapy.
    Aliment Pharmacol Ther, 21(9): 1085-90. [Abstract] [Full-text]

© 2004-2010 Radiotherapy Research Today. All Rights Reserved.